These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. Dithiocarbamate pesticides affect glutamate transport in brain synaptic vesicles. Vaccari A; Saba P; Mocci I; Ruiu S J Pharmacol Exp Ther; 1999 Jan; 288(1):1-5. PubMed ID: 9862745 [TBL] [Abstract][Full Text] [Related]
11. Structural significance of azaheterocyclic amines related to Parkinson's disease for dopamine transporter. Matsubara K; Senda T; Uezono T; Fukushima S; Ohta S; Igarashi K; Naoi M; Yamashita Y; Ohtaki K; Hayase N; Akutsu S; Kimura K Eur J Pharmacol; 1998 May; 348(1):77-84. PubMed ID: 9650834 [TBL] [Abstract][Full Text] [Related]
12. Inhibition by dizocilpine (MK-801) of striatal dopamine release induced by MPTP and MPP+: possible action at the dopamine transporter. Clarke PB; Reuben M Br J Pharmacol; 1995 Jan; 114(2):315-22. PubMed ID: 7881731 [TBL] [Abstract][Full Text] [Related]
13. Active uptake of MPP+, a metabolite of MPTP, by brain synaptosomes. Chiba K; Trevor AJ; Castagnoli N Biochem Biophys Res Commun; 1985 May; 128(3):1228-32. PubMed ID: 3873939 [TBL] [Abstract][Full Text] [Related]
14. Interaction between a hydroxypiperidine analogue of 4-(2-benzhydryloxy-ethyl)-1-(4-fluorobenzyl)piperidine and Aspartate 68 in the human dopamine transporter. Zhen J; Maiti S; Chen N; Dutta AK; Reith ME Eur J Pharmacol; 2004 Dec; 506(1):17-26. PubMed ID: 15588620 [TBL] [Abstract][Full Text] [Related]
15. Inhibitory effect of reserpine on dopamine transporter function. Metzger RR; Brown JM; Sandoval V; Rau KS; Elwan MA; Miller GW; Hanson GR; Fleckenstein AE Eur J Pharmacol; 2002 Dec; 456(1-3):39-43. PubMed ID: 12450567 [TBL] [Abstract][Full Text] [Related]
16. Implication of dopamine transporter system on 1-methyl-4-phenylpyridinium and rotenone effect in striatal synaptosomes. Bougria M; Vitorica J; Cano J; Machado A Eur J Pharmacol; 1995 Nov; 291(3):407-15. PubMed ID: 8719427 [TBL] [Abstract][Full Text] [Related]
17. PI 3-kinase regulation of dopamine uptake. Carvelli L; Morón JA; Kahlig KM; Ferrer JV; Sen N; Lechleiter JD; Leeb-Lundberg LM; Merrill G; Lafer EM; Ballou LM; Shippenberg TS; Javitch JA; Lin RZ; Galli A J Neurochem; 2002 May; 81(4):859-69. PubMed ID: 12065645 [TBL] [Abstract][Full Text] [Related]
18. Studies of the biogenic amine transporters. VIII: identification of a novel partial inhibitor of dopamine uptake and dopamine transporter binding. Rothman RB; Dersch CM; Carroll FI; Ananthan S Synapse; 2002 Mar; 43(4):268-74. PubMed ID: 11835522 [TBL] [Abstract][Full Text] [Related]
19. Synthesis and biological evaluation of pentacyclo[5.4.0.0(2,6).0(3,10).0(5,9)]undecane derivatives as potential therapeutic agents in Parkinson's disease. Geldenhuys WJ; Malan SF; Murugesan T; Van der Schyf CJ; Bloomquist JR Bioorg Med Chem; 2004 Apr; 12(7):1799-806. PubMed ID: 15028270 [TBL] [Abstract][Full Text] [Related]
20. Evidence for the sequential formation of two complexes between an uptake inhibitor, GBR 12783 [1-[2-(diphenylmethoxy)ethyl]-4-(3-phenyl-2-propenyl)piperazine], and the neuronal transporter of dopamine. Do-Régo JC; Hue H; Costentin J; Bonnet JJ J Neurochem; 1999 Jan; 72(1):396-404. PubMed ID: 9886093 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]